San Francisco, CA, United States of America

Jeffrey Yang

This inventor holds 1 USPTO granted patent. Top assignee: University of California. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey Yang. Retrieved from https://idiyas.com/inventor/jeffrey-yang-fbh00wn5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Jeffrey Yang in Chemotherapy Delivery

Introduction

Jeffrey Yang is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of medical technology, particularly in the area of chemotherapy delivery systems. His innovative work focuses on improving the efficacy and safety of cancer treatments.

Latest Patents

One of Jeffrey Yang's notable patents is for a copolymer membrane designed for high-dose chemotherapy delivery during transarterial chemoembolization. This invention involves a porous copolymer membrane composed of poly(styrene sulfonate)-block-polyethylene-block-poly(styrenesulfonate) for the absorption of doxorubicin. Additionally, it includes a chemofiltration catheter that incorporates this membrane, enhancing the delivery of chemotherapy directly to the tumor site.

Career Highlights

Jeffrey Yang is affiliated with the University of California, where he continues to advance research in medical technologies. His work has garnered attention for its potential to improve patient outcomes in cancer treatment.

Collaborations

He has collaborated with notable colleagues, including Anand S Patel and Xi Chelsea Chen, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jeffrey Yang's contributions to the field of chemotherapy delivery exemplify the impact of innovative thinking in medical technology. His work not only addresses critical challenges in cancer treatment but also paves the way for future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…